As many investigational cell and gene therapies continue to advance and demonstrate their clinical and commercial potential, companies including smaller biotechnology firms and larger ...

An accurate cell count is critical for cell and gene therapy, says Beom Choi from InnoBation Bio, a company based in Seoul that uses NanoEntek’s fluorescence cell counter. “The exact number of ...

Cell and gene therapy presents a potential solution to these challenges, offering the possibility to treat diseases at a cellular or genetic level. However, as promising as these therapies are ...

The global Cell and Gene Therapy Market is valued at $20.5 billion in 2024 and is projected to reach a value of $128.8 billion by 2035. This growth represents a Compound Annual Growth Rate (CAGR) of ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Combining cell and gene therapeutic approaches is reshaping basic and translational research, yielding new models and tools that help scientists delve deeper into the drivers of health and disease.

Nevertheless, the Australian company has recently decided to shutter its cell and gene therapy R&D hub in Pasadena, California, as it deprioritizes ex vivo lentiviral-based gene therapy work in ...

In July 2023, Sanofi expanded an existing partnership with Scribe Therapeutics to use its CRISPR-based gene-editing technology to develop both in vivo and ex vivo cancer cell therapies.

These functioned as a rogues’ gallery in preparation for future fisticuffs: if the same piece of DNA were seen again, the cell would know ... Building a gene editor took months.

Germany-based Miltenyi Biotec, a provider of cell and gene therapy (CGT) solutions, opened a dedicated cell & gene therapy centre-of-excellence (CoE) in the Genome Valley here. The MITC ...

Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to new health guidelines which were hailed as marking a “significant ...